Long Term Follow-Up of Patients with Chronic Hepatitis C Treated with Alpha Interferon
Interferon alpha (IFN) treatment for chronic hepatitis C induces a sustained biochemical and virological response at six months after completing 24 weeks of therapy in approximately 10% of patients. The long term durability of this ‘sustained’ response is still controversial. The aim of this multice...
Saved in:
| Main Authors: | Jane D Collier, Paul A Adams, Victor Feinman, Cameron Ghent, Helga Witt-Sullivan, Gerald Minuk, Mel Krajden, Jenny Heathcote |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2000-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2000/405638 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Publicly Funded, Pegylated Interferon-Alpha Treatment in British Columbia: Disparities in Treatment Patterns for People with Hepatitis C
by: Priscilla C Hsu, et al.
Published: (2008-01-01) -
Hepatitis
by: Mel Krajden
Published: (2001-01-01) -
The Use of Budesonide in the Treatment of Autoimmune Hepatitis in Canada
by: Iman Zandieh, et al.
Published: (2008-01-01) -
Diffuse Skin Reaction in Patient with Hepatitis B, Treated with Two Different Formulations of Pegylated Interferon
by: Piotr Milkiewicz, et al.
Published: (2005-01-01) -
Indications for Interferon/Ribavirin Therapy in Hepatitis C Patients: Findings from a Survey of Canadian Hepatologists
by: Peter Wang, et al.
Published: (2003-01-01)